Cytopia enters Progen squabble
28 January, 2009 by Kate McDonaldCytopia calls for board spill and offers merger for troubled Progen
Phase III positive for Clinuvel
22 January, 2009 by Kate McDonaldGood early results in Phase III trial for sun intolerance drug
Parkinson’s indication for LCT
11 December, 2008 by Kate McDonaldRat studies show encapsulated brain cells useful in Parkinson’s model
Arana begins Phase II
11 December, 2008 by Kate McDonaldMulti-centre Phase II trial in rheumatoid arthritis begins
Head and neck for Viralytics
09 December, 2008 by Kate McDonaldViralytics finds fourth indication for oncolytic virus technology
Promising results for CML
09 December, 2008 by Kate McDonaldChemGenex compound shows promising results in drug-resistant CML
HealthLinx scores high with OvPlex
08 December, 2008 by Kate McDonaldHealthLinx reports 98 per cent efficiency with ovarian cancer diagnostic
Phosphagenics reports pain relief
08 December, 2008 by Kate McDonaldPhosphagenics reports early results from lidocaine topical delivery trial
Two more for AtCor
08 December, 2008 by Kate McDonaldDrug trial contracts bring total worth to US $5.7m in past six months
Crop scientist one of Nature’s finest
04 December, 2008 by Kate McDonaldAustralian named as 'researcher who could change the world'
Metabolic-PolyNovo deal dies
02 December, 2008 by Kate McDonaldMetabolic shareholders put the kybosh on acquisition of PolyNovo
Novogen subsidiary files IND
02 December, 2008 by Kate McDonaldMarshall Edwards files IND for chemo-sensitising agent
Prana looks at Huntington’s
02 December, 2008 by Kate McDonaldPrana to investigate lead candidate in Huntington’s disease
